FDA Inspection 785402 — Altaire Pharmaceuticals, Inc.

Altaire Pharmaceuticals, Inc. — FEI 1000119582

The FDA completed an inspection of Altaire Pharmaceuticals, Inc. on June 7, 2012 in Aquebogue, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 7, 2012
Fiscal Year
2012
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Aquebogue, NY (United States)

Citations

IDCFRDescription
116221 CFR 211.28(a)Protective Apparel Not Worn
192021 CFR 211.166(a)(3)Valid stability test methods
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
358521 CFR 211.110(a)Control procedures to monitor and validate performance
435021 CFR 211.160(b)(3)Drug products-sampling procedures/specifications